Tel Aviv, Tel Aviv, IsraelFounded 202138+ employeesPrivate
$30.5M raisedSeries A· last: seed (May 2022)· 2 rounds
Backed by(20 investors)
MS&AD Ventures · Lead+12 more
NeuraLight is developing a software-based platform for eye movement analysis, providing an objective and sensitive tool in neurodegenerative diseases. Our platform is successfully used in several CNS clinical trials, presenting the ability of using eye movement analysis to differentiate patients from healthy subjects, stratify different subgroups, and monitor disease progression.
